FCG Advisors’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | $507K | Sell |
5,832
-202
| -3% | -$17.6K | 0.12% | 95 |
|
2020
Q2 | $527K | Sell |
6,034
-125
| -2% | -$10.9K | 0.14% | 76 |
|
2020
Q1 | $508K | Buy |
6,159
+501
| +9% | +$41.3K | 0.14% | 77 |
|
2019
Q4 | $536K | Sell |
5,658
-104
| -2% | -$9.85K | 0.15% | 79 |
|
2019
Q3 | $501K | Buy |
5,762
+111
| +2% | +$9.65K | 0.15% | 80 |
|
2019
Q2 | $516K | Sell |
5,651
-625
| -10% | -$57.1K | 0.16% | 78 |
|
2019
Q1 | $541K | Sell |
6,276
-176
| -3% | -$15.2K | 0.18% | 72 |
|
2018
Q4 | $496K | Buy |
6,452
+154
| +2% | +$11.8K | 0.19% | 70 |
|
2018
Q3 | $486K | Hold |
6,298
| – | – | 0.17% | 74 |
|
2018
Q2 | $426K | Buy |
6,298
+1,433
| +29% | +$96.9K | 0.15% | 79 |
|
2018
Q1 | $352K | Sell |
4,865
-35
| -0.7% | -$2.53K | 0.12% | 91 |
|
2017
Q4 | $365K | Buy |
4,900
+134
| +3% | +$9.98K | 0.14% | 80 |
|
2017
Q3 | $362K | Hold |
4,766
| – | – | 0.13% | 79 |
|
2017
Q2 | $357K | Buy |
4,766
+13
| +0.3% | +$974 | 0.12% | 100 |
|
2017
Q1 | $313K | Sell |
4,753
-160
| -3% | -$10.5K | 0.13% | 85 |
|
2016
Q4 | $321K | Sell |
4,913
-366
| -7% | -$23.9K | 0.14% | 79 |
|
2016
Q3 | $373K | Sell |
5,279
-99
| -2% | -$7K | 0.11% | 76 |
|
2016
Q2 | $398K | Buy |
+5,378
| New | +$398K | 0.12% | 82 |
|
2015
Q3 | – | Sell |
-2,390
| Closed | -$211K | – | 83 |
|
2015
Q2 | $211K | Sell |
2,390
-377
| -14% | -$33.3K | 0.17% | 76 |
|
2015
Q1 | $244K | Sell |
2,767
-658
| -19% | -$58K | 0.13% | 87 |
|
2014
Q4 | $292K | Buy |
3,425
+394
| +13% | +$33.6K | 0.14% | 90 |
|
2014
Q3 | $211K | Sell |
3,031
-413
| -12% | -$28.8K | 0.14% | 70 |
|
2014
Q2 | $279K | Buy |
3,444
+292
| +9% | +$23.7K | 0.21% | 66 |
|
2014
Q1 | $240K | Sell |
3,152
-73
| -2% | -$5.56K | 0.17% | 68 |
|
2013
Q4 | $232K | Buy |
+3,225
| New | +$232K | 0.16% | 66 |
|